12 Health Care Stocks Moving In Thursday's After-Market Session
Portfolio Pulse from Benzinga Insights
The article highlights the performance of 12 health care stocks during Thursday's after-market session. Notable gainers include Venus Concept (VERO), Cyclacel Pharmaceuticals (CYCC), and Applied DNA Sciences (APDN). Significant losers include Biomea Fusion (BMEA), Tevogen Bio Holdings (TVGN), and Bright Green (BGXX).
June 06, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Bright Green (BGXX) stock fell 8.55% to $0.32.
The stock's decline suggests negative sentiment or news affecting the stock.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Biomea Fusion (BMEA) stock fell 61.9% to $4.3 during Thursday's after-market session.
The significant drop suggests negative news or sentiment impacting the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Tevogen Bio Holdings (TVGN) stock fell 13.49% to $0.77.
The stock's decline indicates negative market reaction or news.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Applied DNA Sciences (APDN) stock moved upwards by 8.27% to $0.59.
The stock's rise indicates positive market reaction or news.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cyclacel Pharmaceuticals (CYCC) shares increased by 8.58% to $2.15.
The stock's upward movement suggests positive investor sentiment or news.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Venus Concept (VERO) stock rose 131.0% to $1.43 during Thursday's after-market session.
The significant price increase indicates strong positive sentiment or news affecting the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100